克明面業(002661.SZ):上半年淨利預增72.95%-120.99%
格隆匯5月21日丨克明面業(002661.SZ)披露2020年半年度業績預告,公司預計2020年1-6月實現歸屬於上市公司股東的淨利潤1.8億元-2.3億元,同比增長72.95%-120.99%。報告期內公司業績較上年同期增長的主要原因:
1.疫情期間,在食品需求旺盛的情況下,公司品牌效益和強大的渠道網絡凸現其價值。掛麪類主食和方便麪屬於家庭剛需品,公司及時調整產品結構,推動高端掛麪銷售。
2.同時由於產品供不應求,公司主動調整促銷力度,買贈促銷活動大幅減少,毛利率較上期大幅度提高,公司半年度實現較好的利潤增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.